Topic: Neuroscience
Scientists in Germany discovered that a gene called CD99L2 is responsible for X-linked spastic ataxia. This breakthrough helps explain a previously unknown neurological disorder and sheds light on how certain neurodegenerative diseases develop.
Rare movement disorders can be challenging to diagnose, even with advanced DNA sequencing technologies. Researchers in Germany made a significant discovery by analyzing the genetic information of over 2,800 people with ataxia, hereditary spastic paraplegia, and dystonia.
They found that harmful variants in the CD99L2 gene were the cause of X-linked spastic ataxia. This finding was published in Nature Communications and provides new insights into how certain neurodegenerative diseases develop.
The research team discovered that the protein produced by CD99L2 works as an activating partner for CAPN1, a calcium-dependent protease already known to be involved in hereditary spastic paraplegia and ataxia. This means that defects in CD99L2 reduce the activation of CAPN1, which disrupts important neuronal signaling pathways.
The study highlights the importance of combining genetic testing with functional studies of how genes operate inside cells. By working together, scientists can better understand the underlying causes of rare neurological disorders and develop more effective diagnostic tools.
Why It Matters
This breakthrough has significant implications for Indian students interested in neuroscience or medicine. Understanding the genetic causes of rare neurological disorders can lead to improved diagnosis and treatment options, ultimately improving the quality of life for patients affected by these conditions.
Key Facts
- A team of scientists in Germany discovered that CD99L2 gene variants are responsible for X-linked spastic ataxia.
- The study analyzed genetic information from over 2,800 people with rare movement disorders.
- Defects in the CD99L2 gene reduce the activation of CAPN1, disrupting important neuronal signaling pathways.
Key Terms
- CD99L2
- A gene that plays a critical role in maintaining normal neuronal signaling.
Implications
This breakthrough has significant implications for Indian students interested in neuroscience or medicine. Understanding the genetic causes of rare neurological disorders can lead to improved diagnosis and treatment options, ultimately improving the quality of life for patients affected by these conditions.
Source: https://www.sciencedaily.com/releases/2026/06/260612032046.htm
Journal Reference:
- Benita Menden, Rana D. Incebacak Eltemur, German Demidov, Marc Sturm, Joohyun Park, Chrisovalantou Huridou, Florian Fath, Astrid Nümann, Alexander Baumann, Illja J. Diets, Claudia Dufke, Martin Regensburger, Maria Rönnefarth, Vera Wilke, Nienke van Os, Stefan Vielhaber, Tim W. Rattay, Zacharias Kohl, Susana Peralta, Priscila Pereira Sena, Melanie Kellner, Nadine Weissert, Andreas Traschütz, Lena Zeltner, Kai Boelmans, Natalie Deininger, Leon Schütz, Caspar Gross, Ana Beatriz Hinojosa Amaya, Katrin Raupach, Holger Hengel, Florian Harmuth, Jakob Admard, Ingrid Bader, Sarah Baumann, Friedemann Bender, Andrea Bevot, Almut Bischoff, Felix Boschann, Rebecca Buchert, Daniel Buchzik, Nicolas Casadei, Claudia B. Catarino, Isabell Cordts, Kirsten Cremer, Marion Doebler-Neumann, Nadja Ehmke, Miriam Elbracht, Ruth J. Falb, Thomas Feindt, Zofia Fleszar, Lea Gerstner, Dieter Gläser, Ute Grasshoff, Sarah Grosch, Kathrin Grundmann, Alexander Gutschalk, Manja Haaga, Stefanie Hayer, Ute Hehr, Yorck Hellenbroich, Wolfram Henn, Barbara Herr, Rebecca Herzog, Veronka Horber, Jonas Deppe, Nadja Kaiser, Christiane Kehrer, Martin Kehrer, Jan Kern, Christoph Keßler, Katharina Khuller, Hannah Klinkhammer, Urania Kotzaeridou, Peter Krawitz, Martina Kreiss, Hanna Küpper, Alice Kuster, Lucia Laugwitz, Anne Lesemann, Nadine Lichey, Tobias Linden, Boris Macek, Janine Magg, Elisabeth Mangold, Eva Manka, Iris Marquardt, Karl Mehnert, David Mengel, Susanne Morlot, Barbara Oehl-Jaschkowitz, Martje G. Pauly, Melanie Philipp, Florentine Radelfahr, Maren Rautenberg, Angelika Riess, Carsten Saft, Beate Schlotter-Weigel, Axel Schmidt, Eva M. C. Schwaibold, Veronika Spahlinger, Stephanie Spranger, Katharina Marie Steiner, Claudia Stendel, Andreas Thieme, Andreas Tzschach, Ana Velic, Sarah Wiethoff, Carlo Wilke, Stephan Züchner, Simone Zittel, Nienke van Os, Bart van de Warrenburg, Ralf A. Husain, Marcus Deschauer, Felix Distelmaier, Andreas Dufke, Holm Graessner, Bernhard Hemmer, Heike Jacobi, Thomas Klockgether, Thomas Klopstock, Xenia Kobeleva, Georg-Christoph Korenke, Alma Kuechler, Gregor Kuhlenbäumer, Ingo Kurth, Huu Phuc Nguyen, Gilbert Wunderlich, Kirsten E. Zeuner, Stephan Klebe, Michaela Auer-Grumbach, Michaela Butryn, Jürgen Winkler, Dagmar Timmann, Matthis Synofzik, Bart van de Warrenburg, Rebecca Schüle, Ludger Schöls, Stephan Ossowski, Olaf Riess, Jonasz J. Weber, Tobias B. Haack. Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia. Nature Communications, 2026; 17 (1) DOI: 10.1038/s41467-026-69337-9
.
Leave a Comment